1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with s6c sarafotoxin in 13 studies
Studies (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Trials (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Recent Studies (post-2010) (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Studies (s6c sarafotoxin) | Trials (s6c sarafotoxin) | Recent Studies (post-2010) (s6c sarafotoxin) |
---|---|---|---|---|---|
123 | 3 | 1 | 595 | 3 | 37 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (84.62) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, GR; Douglas, SA; Elliott, JD; Ohlstein, EH | 2 |
Mitchell, MP; Ohlstein, EH; Sauermelch, CF; Sulpizio, AC; Willette, RN; Zhang, H | 1 |
Fletcher, T; Gellai, M; Nambi, P; Pullen, M | 1 |
Beck, G; Hay, DW; Luttmann, MA; Ohlstein, EH | 1 |
Beck, GR; Hay, DW; Luttmann, MA; Mitchell, MP; Ohlstein, EH; Sauermelch, CF; Willette, RN | 1 |
Hay, DW; Luttmann, MA | 1 |
De Wolf, R; Fletcher, T; Gellai, M; Nambi, P | 1 |
Elliott, JD; Guiney, S; Luengo, JI; Ohlstein, EH; Sauermelch, CF; Storer, BL; Willette, RN; Xiang, JN | 1 |
Docherty, C; MacLean, MR | 1 |
Goldie, RG; Hay, DW; Luttmann, MA; Muccitelli, RM | 1 |
Burrell, KM; Dawson, PJ; Kaumann, AJ; Molenaar, P | 1 |
Ao, Z; Douglas, SA; Goldie, RG; Hay, DW; Luttmann, MA; Moesker, RM; Rigby, PJ; Self, GJ | 1 |
13 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and s6c sarafotoxin
Article | Year |
---|---|
Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein.
Topics: Animals; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Indans; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Peptide Fragments; Peptides, Cyclic; Rabbits; Receptors, Endothelin; Saphenous Vein; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Viper Venoms | 1995 |
Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
Topics: Animals; Arteries; Basilar Artery; Cells, Cultured; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Indans; Ischemic Attack, Transient; Male; Mitogens; Muscle, Smooth, Vascular; Spinal Cord; Subarachnoid Hemorrhage; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms | 1994 |
Agonist-dependent inhibition by peptide and nonpeptide endothelin receptor antagonists in the rabbit isolated pulmonary artery.
Topics: Animals; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; In Vitro Techniques; Indans; Male; Pulmonary Artery; Rabbits; Receptors, Endothelin; Vasoconstriction; Viper Venoms | 1995 |
Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
Topics: Animals; Blood Pressure; Endothelin Receptor Antagonists; Hindlimb; Humans; Indans; Male; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Regional Blood Flow; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Viper Venoms | 1996 |
Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
Topics: Animals; Bronchi; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; Indans; Male; Muscle, Smooth, Vascular; Peptide Fragments; Peptides, Cyclic; Pulmonary Artery; Rabbits; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 1996 |
Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Topics: Animals; Blood Pressure; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Heart Rate; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Pulmonary Artery; Vasoconstrictor Agents; Viper Venoms | 1997 |
Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.
Topics: Animals; Bronchi; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Guinea Pigs; In Vitro Techniques; Indans; Kinetics; Male; Muscle Contraction; Muscle, Smooth; Oligopeptides; Peptides, Cyclic; Piperidines; Viper Venoms | 1997 |
Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Interactions; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Indans; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms | 1997 |
Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
Topics: Animals; Benzofurans; Carboxylic Acids; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Indans; Injections, Intravenous; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Propionates; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 1998 |
Development of endothelin receptors in perinatal rabbit pulmonary resistance arteries.
Topics: Acetylcholine; Animals; Azepines; Endothelin-1; In Vitro Techniques; Indans; Indoles; Norepinephrine; Oligopeptides; Piperidines; Potassium Chloride; Pulmonary Artery; Rabbits; Receptors, Endothelin; Serotonin; Vascular Resistance; Viper Venoms | 1998 |
Endothelin receptors and calcium translocation pathways in human airways.
Topics: Bronchi; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Humans; In Vitro Techniques; Indans; Inositol Phosphates; Muscle Contraction; Muscle, Smooth; Nicardipine; Peptides, Cyclic; Potassium Chloride; Receptors, Endothelin; Viper Venoms | 1999 |
Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Appendage; Coronary Vessels; Dose-Response Relationship, Drug; Endothelins; Female; Heart Ventricles; Humans; In Vitro Techniques; Indans; Male; Middle Aged; Muscle Contraction; Myocardial Contraction; Receptors, Endothelin; Viper Venoms | 2000 |
Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout mice.
Topics: Animals; Autoradiography; Endothelins; Female; Genotype; In Vitro Techniques; Indans; Ligands; Male; Mice; Mice, Knockout; Muscle Contraction; Muscle, Smooth; Peptides, Cyclic; Pyrrolidines; Receptor, Endothelin B; Receptors, Endothelin; Trachea; Viper Venoms | 2001 |